Overview

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

Status:
Withdrawn

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

To demonstrate the safety and efficacy of adjunctive therapy with the Amikacin Fosfomycin Inhalation System (AFIS) versus aerosolized placebo in mechanically ventilated patients with Gram-negative and / or Gram-positive bacterial colonization.

Phase:

Phase 2

Details

Lead Sponsor:

Cardeas Pharma

Treatments:

Amikacin
Fosfomycin
Pharmaceutical Solutions